Gregory de Lissovoy, PhD

home / authors / gregory-de-lissovoy-phd

Articles

Site Logo
March 1st 2008

Can Managed Care Organizations Partner With Manufacturers for Comparative Effectiveness Research?

Bryan R. Luce, PhD L. Clark Paramore, MSPH Bhash Parasuraman, PhD Bengt Liljas, PhD Gregory de Lissovoy, PhD

Two case studies examine the benefits of manufacturers and managed care organizations partnering in pragmatic or practical clinical trials to generate real-world evidence.

Site Logo
December 1st 2002

Economic Evaluation of Enoxaparin as Prophylaxis Against Venous Thromboembolism in Seriously Ill Medical Patients: A US Perspective

Gregory de Lissovoy, PhD Prasun Subedi, BS

Site Logo
November 1st 2001

Economic Issues in the Treatment and Prevention of Deep Vein Thrombosis From a Managed Care Perspective

Gregory de Lissovoy, PhD

Site Logo
May 1st 2000

Relationship of Hemoglobin A1C, Age of Diabetes Diagnosis, and Ethnicity to Clinical Outcomes and Medical Costs in a Computer-Simulated Cohort of Persons with Type 2 Diabetes

Gregory de Lissovoy, PhD Dara A. Ganoczy, MPH Nancy F. Ray, MS

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Long-Term Follow-Up from CheckMate 9LA at ASCO 2024
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Insights from the TROPION-Lung05 Trial at ASCO 2024
Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School
Published: July 24th 2024 | Updated: July 27th 2024
Examining Trends, Future Directions in AI and Health Care
Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD
Alfred L. Garfall, MD, an expert on multiple myeloma
Published: July 24th 2024 | Updated: July 27th 2024
Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo